SCTX
Scribe Therapeutics Inc.
There isn't enough reported data to score SCTX yet.
SCTX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate SCTX's fundamentals.
SCTX PE Valuation
SCTX has no meaningful PE right now: it lost money over the past year.
SCTX Forward outlook
There aren't enough analyst estimates for SCTX to show an outlook.
SCTX Earnings Per Share
SCTX Quarterly Revenue
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -664% | N/A |
| Q2 2026 | -490% | N/A |
SCTX Free Cash Flow
SCTX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +486% | +12M shares |
SCTX Net Leverage
SCTX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SCTX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.9 | Neutral |
| Stochastic | 9.7 | Oversold |
SCTX's weekly RSI is 34 (neutral) and its Stochastic is 10 (oversold).
SCTX PE vs Healthcare Sector
SCTX has no meaningful PE right now: it lost money over the past year.
SCTX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.9 | 4.8% below |
SCTX is in a downtrend: it's below all one of its weekly moving averages, and 4.8% below its 8-week average.
SCTX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $21.7 | $17.0 | -22% |
It's down 22% so far in 2026.